Psychologists and psychoactive drugs.
Research on psychoactive drugs: antianxiety, antidepressant, and antipsychotic was reviewed. The drug families and their usual side effects were described. Proliferation of drug use, polypharmacy, and tardive dyskinesia were seen as areas of concern; advances in biological explanations of schizophrenia and manic-depressive disorders, and increasing knowledge about the brain's neurotransmitters brightened the investigative efforts.
D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000378:metabolism; D011584:Psychology; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000209:etiology
D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D008996:Monoamine Oxidase Inhibitors; D018377:Neurotransmitter Agents; D011619:Psychotropic Drugs